Trial intelligence / Profile preview

Fluconazole Regimens for OPC in HIV

NCT00553137Phase 4Completed

Sponsor
Dutch Research Council
Start
Nov 2006
Primary completion
Dec 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of fluconazole in oropharyngeal candidiasis (OPC) (2 arms), sponsored by Dutch Research Council. Primary endpoint: Clinical and Mycological Cure at 2 weeks. Started Nov 2006; status: completed.

02

Drugs

fluconazole
03

Conditions

oropharyngeal candidiasis (OPC)

Beyond the preview

Go deeper on NCT00553137.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00553137.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call